These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 3916408)
21. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475 [TBL] [Abstract][Full Text] [Related]
22. Tumor metastasis: achievements, dilemmas, and future, a summary of the conference. Milas L Symp Fundam Cancer Res; 1983; 36():457-67. PubMed ID: 6679094 [No Abstract] [Full Text] [Related]
23. Natural killer cells in innate immunity and cancer. Becknell B; Caligiuri MA J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751 [No Abstract] [Full Text] [Related]
24. Natural killer (NK) cells and their possible roles in resistance against disease. Herberman RB Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848 [No Abstract] [Full Text] [Related]
25. The natural killer cell. Floyd RA; Fernandes G; Good RA Clin Bull; 1979; 9(4):146-56. PubMed ID: 232015 [No Abstract] [Full Text] [Related]
26. [Natural cytotoxic cells (NK cells)]. Frydecka I Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740 [No Abstract] [Full Text] [Related]
27. [Natural killers and macrophages: their activity in leukemias]. Fi FT Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945 [No Abstract] [Full Text] [Related]
28. [Surface markers of blood lymphocytes in cancer patients with special reference to natural killer cells]. Utsunomiya A Igaku Kenkyu; 1987 Sep; 57(5):284-300. PubMed ID: 3448874 [No Abstract] [Full Text] [Related]
29. [Role of the neutrophils in the pathogenesis of malignant growth]. Kashulina AP; Tereshchenko IP Eksp Onkol; 1985; 7(6):3-9. PubMed ID: 3910404 [TBL] [Abstract][Full Text] [Related]
30. Natural killer cells and their possible roles in host resistance against tumors. Herberman RB Transplant Proc; 1984 Apr; 16(2):476-8. PubMed ID: 6719548 [No Abstract] [Full Text] [Related]
31. The participation of natural cytotoxicity in the control of malignant disease. Draca SR Panminerva Med; 1993 Sep; 35(3):123-6. PubMed ID: 8090524 [TBL] [Abstract][Full Text] [Related]
34. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells). Fujii S Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396 [No Abstract] [Full Text] [Related]
35. [NK cells. I. Their development and biological activity]. Mikołajczyk-Cichońska A; Gościcka T Postepy Hig Med Dosw; 2001; 55(5):655-71. PubMed ID: 11795201 [TBL] [Abstract][Full Text] [Related]
36. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells. Fresa KL; Murasko DM Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213 [TBL] [Abstract][Full Text] [Related]
38. Surveillance role of various leukocytes in preventing the outgrowth of potentially malignant cells. Urban J; Schreiber H Contemp Top Immunobiol; 1984; 13():225-42. PubMed ID: 6610532 [No Abstract] [Full Text] [Related]
39. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Wilson SB; Delovitch TL Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269 [TBL] [Abstract][Full Text] [Related]
40. [Natural killer cells in the interferon therapy of cancer patients]. Shparyk IaV; Bilynskiĭ BT; Shloma DV Vopr Onkol; 1991; 37(2):136-43. PubMed ID: 1707569 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]